Eyepoint Pharmaceuticals Inc (EYPT)
US$ 11.630.35%
Price Chart
Key Statistics
Market Cap
$ 419.75M
P/E Ratio
0.00
Revenue (TTM)
$ 56.04M
Volume
536.93K
52W High
$ 13.98
52W Low
$ 3.91
Dividend Yield
0.00%
Beta
1.60
Technicals
50-Day MA
6.0288
200-Day MA
7.8644
52 Week High
13.985
52 Week Low
3.91
About EYPT
EyePoint Pharmaceuticals, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Employees
165
Headquarters
Watertown, MA
CEO
Dr. Jay S. Duker M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg